Skip to content

Clinical trials

Phase 2 Gastrointestinal Stromal Tumors trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Stromal Tumors Phase: Phase 2 Country / region: Germany Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20081
20111
20122
20141
20172
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC2
Novartis Pharmaceuticals2
Eli Lilly and Company1
Fore Biotherapeutics1
Scandinavian Sarcoma Group1
Sebastian Bauer1
Swiss Cancer Institute1
Technical University of Munich1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Stromal Tumors10
Biliary Tract Neoplasms2
Glioma2
Thyroid Carcinoma, Anaplastic2
Breast Neoplasms1
Carcinoma, Hepatocellular1
Cholangiocarcinoma1
Fallopian Tube Neoplasms1
Fibrosarcoma1
Hemangiosarcoma1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.